Symposium

Join internationally recognized ILD experts Steven D. Nathan, MD, Kevin R. Flaherty, MD, and Ayodeji Adegunsoye, MD, as they explore the latest advances transforming the diagnosis and management of fibrotic interstitial lung diseases (ILDs).

This interactive symposium combines expert insights, real-world cases, and live audience polling to help clinicians diagnose ILD earlier, recognize disease progression, optimize antifibrotic therapy, and apply emerging evidence to personalize patient care. Leave with practical strategies you can implement immediately to improve outcomes for patients with fibrotic ILD.

Please contact Colleen Goodchild for more information: cgoodchild@practicepointcme.com 813-925-7145

FACULTY

Steven D. Nathan, MD, FCCP

Schar Chair
Medical Director, Advanced Lung Disease and Transplant Program
Inova Fairfax Hospital

Kevin R. Flaherty, MD

Director, Interstitial Lung Disease Program
University of Michigan Health

Ayodeji Adegunsoye, MD, MSc, PhD, FCCP

Professor of Medicine
Scientific Director, Interstitial Lung Disease Program
University of Chicago Medicine

This activity is provided in collaboration with Rush University Medical Center and Practice Point Communications.

Supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and United Therapeutics, a public benefit company

Practice Point Communications and Rush University Medical Center do not share your name or contact information with any other party.

This symposium is not supported, endorsed, or accredited by the American College of Chest Physicians.